Radiotherapy of Ductal Carcinoma In Situ

Breast care

David Krug¹  Rainer Souchon¹ 

[1] aRadioonkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Germany

关键词: Ductal carcinoma in situ (DCIS);    Radiotherapy;    Low-risk subgroup;    Boost;    Hypofractionation;   

DOI  :  10.1159/000437452

学科分类：泌尿医学

来源: S Karger AG

【 摘 要 】

Ductal carcinoma in situ (DCIS) is a heterogeneous disease in both its biology and clinical course. In the past, recurrence rates after breast-conserving surgery have been as high as 30% after 10 years. The introduction of mammography screening and advances in imaging have led to an increase in the detection of DCIS. The focus of this review is on the role of radiotherapy in the multidisciplinary treatment, including current developments in hypofractionation and boost delivery, and attempts to define low-risk subsets of DCIS for which the need for adjuvant radiation is repeatedly questioned.

【 授权许可】

Unknown